Back    Zoom +    Zoom -
<Research>CMBI Raises CHINA LIFE's TP to HKD29, Rating Buy
Recommend
13
Positive
29
Negative
11
CHINA LIFE (02628.HK)'s 1H25 net profit grew 7% YoY to RMB40.9 billion, implying a 31% YoY drop in 2Q25 earnings, according to a report from CMBI.

Despite quarterly fluctuations, CMBI estimated the volatility in CHINA LIFE's insurance service expenses to ease in 3Q25 or 2H25, as the yield on China's 10-year government bonds rebounds.

Related NewsSoochow Securities Lists Top 10 Net Buys, Net Sells by Southbound Funds in HK Mkt Last Wk (Table)
CMBI also considered the decline in CHINA LIFE's 2Q25 net profit as temporary, given that the nosedive in 4Q24 interest rates set a lower base for insurance service performance to recover in 2H25. The company's dividend grew by 19% YoY to RMB0.24, outpacing net profit growth.

CHINA LIFE's target price was raised from HKD20 to HKD29, with a Buy rating.
AAStocks Financial News